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ABSTRACT
Background: Estrogen deficiency in postmenopausal women causes various
health problems, including osteoporosis. Osteoporosis is
a result of imbalances between new bone formation and old bone resorption.
Phytoestrogens can be used as an alternative to increase bone formation and
overcome estrogen deficiency. Semanggi (Marsilea crenata Presl.) is a plant
that contain phytoestrogens. The aim of this research was to investigate the
bone formation activity of n-hexane fraction of Marsilea crenata Presl. leaves
against hFOB 1.19 cells by observing the expression of osteocalcin and
predicting the phytoestrogen contents of the fraction through metabolite
profiling and in silico studies.
Methods: hFOB 1.19 cells were cultured in 24 well microplates and added
the n-hexane fraction of Marsilea crenata Presl. leaves at doses of 62.5, 125,
and 250 ppm. Genistein 1 µM was used as a positive control. Analysis of
osteocalcin expression was conducted using immunocytochemistry with
CLSM. Metabolite profiling was conducted using UPLC-QToF-MS/MS. In silico
study of the compounds found in metabolite profiling was conducted using
molecular docking with PyRx 0.8 software and 1ERE protein.
Results: n-hexane fraction of Marsilea crenata Presl. leaves increased
osteocalcin expression with the optimum dose of 62.5 ppm and a value of
457.35 AU at p <0.05. Metabolite profiling of n-hexane fraction found 26
known compounds, 14 unknown compounds. 10 of the identified compounds
showed ER-β agonists activity.
Conclusions: The n-hexane fraction of Marsilea crenata Presl. leaves
increased bone formation activity. Compounds of the fraction that showed
ER-β agonists activity might be phytoestrogens.
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INTRODUCTION
Postmenopause is among the stages in a series of aging
processes in women. Those in the postmenopausal stage
experience decreased estrogen levels, which cause
various health problems, such as an imbalance between
resorption and bone formation rate. Furthermore, it leads
to decreased bone mass accompanied by damage to bone
microarchitecture, which in turn increases the risk of
fractures and osteoporosis [1, 2, 3].
Hormone Replacement Therapy (HRT) is used in
postmenopausal women to replace estrogen [5]. However,
the long-term use of synthetic estrogen as a hormone
replacement therapy poses various risks, such as uterine
endometrial bleeding, disruption of the blood clotting
process, interfering with enzymes in the liver, nausea,
vomiting, and cancer [3].
The use of natural ingredients as hormone replacement
therapy in postmenopausal women is an alternative to
overcome estrogen deficiency. Phytoestrogens are
compounds in plants whose structure or function is
similar to estrogen. Therefore, they can replace the
body's endogenous estrogens that are less or reduced by
binding with free receptors [4, 5].
Semanggi (Marsilea crenata Presl.) is a traditional plant
and food for people in Surabaya, East Java, and it is
known to contain phytoestrogens. Furthermore, n-hexane
and ethyl acetate fraction of Marsilea crenata Presl. leaves
showed the ability to increase trabecular bone density of
female mice's vertebrae [6, 7, 8]. In vitro studies, n-
hexane extract could increase the proliferation and
differentiation processes of MC3T3-E1 preosteoblast cells
[9]. The presence of phytoestrogens contained in Marsilea
crenata Presl. which is thought to play a role in these
activities. The aims of this research were to investigate
the bone formation activity of the n-hexane fraction of
Marsilea crenata Presl. leaves against hFOB 1.19 cells by
observing the expression of osteocalcin and predicting
the phytoestrogen contents of the fraction through
metabolite profiling and in silico studies.
Phytoestrogen content can increase osteocalsin
production in osteoblasts, which is a marker for bone
formation activity [10, 11]. In vitro bone formation
activity was carried out by observing the added of n-
hexane fraction of Marsilea crenata Presl. leaves on hFOB
1.19 cells and investigated the increased expression of
osteocalcin as a marker [10, 11].
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The great potential of Marsilea crenata Presl., has not
been fully confirmed the phytochemical compounds that
play a role in the resulting activity. So that the in vitro
results were continued to confirm and predict the
compounds that play a role in bone formation activity, by
identifying the metabolite profiling of the n-hexane
fraction of Marsilea crenata Presl. leaves, with Ultra
Performance Liquid Chromatography - Quadrupole Time
of Flight - Mass Spectrometry (UPLC-QToF-MS/MS).
Meanwhile, the estrogen receptor that plays a role in
bone formation activity is ER-β, and it is used as a
molecular docking for the object, where the osteoblasts
responsible for bone formation are strongly influenced by
the bond between estrogen and ER-β [12].
The UPLC-QToF-MS/MS method is an excellent technique
to identify metabolite profiles with high resolution, fast,
more sensitive, as well as time and solvent saving [13].
Also, the use of the in-silico method aims to assist in
preparation development with activity to increase bone
formation based on the principle of observing
physicochemical and the activity of compounds with
certain target proteins. The protein target uses human
ER-β which has a bond with 17β-estradiol with the code
1ERE obtained from protein data bank Research
Collaboratory for Structural Bioinformatics (RCSB) [14,
15]. Through in silico studies, initial hypotheses and
predictions related to the potential activity of compounds
were obtained by correlating the structure and




Marsilea crenata Presl. leaves were collected in Benowo,
Surabaya, Indonesia, and identified in UPT Materia
Medica, Batu, with number 1a17b-18a-1. The leaves were
dried and ground to obtain powdered form. Human fetal
osteoblast cell, hFOB 1.19 (CRL-11372), was purchased
from American Type Cell Culture (ATCC). n-hexane was
purchased from Merck (Merck, Darmstadt, Germany).
Bovine Serum Albumin (BSA), dimethyl sulfoxide (DMSO),
paraformaldehyde (PFA), and Phosphate-Buffered Saline
(PBS) were purchased from Sigma-Aldrich. Anti-mouse
osteocalcin (OCN) were purchased from Abcam.
Dulbecco's Modified Eagle's Medium (DMEM), G418,
penicillin-streptomycin 1%, fetal bovine serum (FBS)
were purchased from Aretha Laboratory, Bandung,
Indonesia. Tween-80, paraformaldehyde, genistein were
purchased from Laboratorium Sentral Ilmu Hayati (LSIH),
Universitas Brawijaya, Malang, Indonesia.
Dichloromethane (DCM), methanol, acetonitrile, and
formic acid as solvent and mobile phase on UPLC-QToF-
MS/MS were purchased from the Central Forensic
Laboratory of the Indonesian National Police's Criminal
Research Agency.
Extraction and fractination
A 1.6 kg of dry powder of Marsilea crenata Presl. Leaves
were extracted with 96% ethanol using the ultrasonic-
assisted methods (Soltec Sonica 5300EP S3, Italy). The
extract was further separated using a liquid-liquid
extraction technique by suspending in 700 ml of water,
and fractionating using n-hexane in a ratio of 1: 1. The n-
hexane fraction was further evaporated using a rotary
evaporator (Heidolph Hei-VAP ML / G3, Germany).
Cell culture
The hFOB 1.19 cells were put in a 75 ml flask and
cultured in a complete medium prepared from a mixture
of DMEM, G418, 1% Penicillin-streptomycin, 10% FBS,
and incubated in a 5% CO2 incubator at 37 °C for 6 days.
During the process, cell development was observed for 24
hours, and the culture medium was replaced at any time
if color is changed due to the depletion of nutrients. After
reaching 80-90% of confluency, cells were seeded on a 24
well microplate.
Osteocalcin measurement
50 mg of n-hexane fraction was mixed with 0.5% Tween-
80 and 0.5% DMSO in a volumetric flask to produce a
5000-ppm solution. The solution was sterilized using a
0.22-micrometer millipore filtration method, and diluted
to produce solutions of 62.5, 125, and 250 ppm [7, 9, 18].
All solutions were then mixed with hFOB 1.19 cell in a 24
well microplate and incubated for 48 hours at 37 °C in a
5% CO2 incubator. 4% PFA was added to the mixture,
followed by 10% BSA. PBS was used to rinse the cells in
every step of the treatment. The Anti-mouse osteocalcin
was added to the microplates and incubated at 4 °C for 24
hours. Microplates were then rinsed with PBS, and anti-
mouse rhodamine was added, then incubated at 37 °C for
1 hour in a dark room. Immunofluorescence analysis was
conducted using CLSM (fluoview Olympus FV1000) at
wavelengths of 543 nm. The immunofluorescence of
markers was analyzed using Olympus Fluoview Ver.4.2a.
software to determine the value of Osteocalcin expression.
Metabolite profiling
The UPLC-QToF-MS/MS method has been developed and
validated according to the regulator guidelines. The n-
hexane fraction was prepared by solid-phase extraction,
and 100 ppm n-hexane fraction extract insolvent. Then
injected 5 µl each into the ACQUITY UPLC® H-Class
System (Waters, USA), which was coupled to an MS
detector Xevo G2-S QToF (Waters, USA). The sample was
separated on an ACQUITY BEH C18 (1.7 µm 2.1 × 50 mm)
with acetonitrile + 0.05% formic acid and water + 0.05%
formic acid as the mobile phase, with a flow rate of 0.2
ml/minute. Also, the results of the UPLC-MS analysis
were processed using MassLynx 4.1 software, to obtain
the data of peak and m/z spectra of each detected peak.
The Compounds of n-hexane fraction of Marsilea crenata
Presl. leaves from the solvent can be predicted using the
ChemSpider website.
In silico study
The receptor structure of ER-β used in this study was
obtained from the Protein Data Bank
(http://www.rcsb.org) with the code 1ERE (14, 15).
Meanwhile, initial preparation was carried out to
separate the internal ligand (17β-estradiol) from its
protein using the Biovia Discovery Studio Visualizer 2016.
Also, secondary metabolites from the n-hexane fraction of
Marsilea crenata Presl. leaves were prepared using the
SwissADME webtool and predicted components of
phytochemical were tested using BOILED-Egg to
determine the penetration of these compounds. Internal
ligand determination and compound testing used
Avogadro 1.90.0, and energy optimization used the
MMF94s method. Also, molecular docking simulations
were performed using PyRx 0.8 and the Autodock Vina.
The receptor-ligand complex from the docking simulation
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The results of the extraction of Marsilea crenata Presl.
leaves with 96% ethanol are 26.5 g and fractionation
obtained 11.9 g n-hexane fraction of Marsilea crenata
Presl. leaves.
Cell culture
hFOB 1.19 cell culture that has been carried out showed
80-90% confluent cells and used in in vitro activity tests.
Osteocalcin measurement
Osteocalcin measurements were done using
immunocytochemistry (ICC) and Confocal Laser Scanning
Microscopy (CLSM) instrument. The ICC makes it possible
to evaluate the cells can produce the desired marker
fluorescence, so that it can measure marker bone
formation, namely osteocalcin expression on hFOB 1.19
cells [10, 11]. The visualization results using CLSM can be
seen (Figure 1). The results of measuring the
fluorescence intensity of osteocalcin were compared with
the negative and positive control (genistein) to determine
bone formation activity against hFOB 1.19 cells in the
form of numbers with arbitrary units (AU). This can be
seen in (Table 1) and the graph results are shown in
(Figure 2).
Metabolite profiling
n-hexane fraction was analyzed using UPLC-QToF-MS/MS
to obtain all its phytochemical components. The result of
ion separation was detected by the detector and
displayed as a chromatogram in dichloromethane and
methanol as a solvent which can be seen in (Figure 3) and
(Figure 4). The total data number of all the compounds
characterized in the n-hexane fraction of Marsilea crenata
Presl. leaves were 40 peak compounds. This can be seen
in (Table 2) and (Table 3). Of all the peaks, only 26 can be
known and 14 are unknown compounds.
In silico study
10 compounds can bind with at least two amino acids HIS
(D: 524), ARG (D: 394), and GLU (D: 353), and their
binding affinity is close to 17β-estradiol. This can be seen
in (Table 4).
DISCUSSION
The hormone estrogen has an important role for women,
including as a protection against osteoporosis. Therefore,
therapies that can be used as prevention and treatment
are principally drugs that act to reduce bone loss and
anabolic agents that stimulate the formation of new bone
[18, 19]. The critical pathogenic mechanism associated
with aging-related skeletal fragility is impaired bone
formation due to an insufficient number of osteoblasts
[20, 21, 22]. This decreased osteoblast number may be
from a reduction in the lifespan of osteoblasts, which is
enhanced by estrogen deficiency [20, 22].
Osteoblasts are primarily known for their bone-building
function, which involves the deposition of an organic
matrix and its subsequent mineralization [22, 23]. One of
the key players in bone endocrinology is osteocalcin or
bone ɤ-carboxyglutamic acid protein, a factor expressed
and secreted solely by osteoblasts and was used as a
serum marker of osteoblastic bone formation [24, 25, 26].
The hFOB 1.19 cells in this study were given genistein as
a positive control and showed increased expression of
osteocalcin. Recently, phytoestrogens such as genistein
have drawn significant attention as these compounds
have been shown to increase bone formation through
estrogen signaling pathways, without increasing cancer
risk [22].
The n-hexane fraction of Marsilea crenata Presl. leaves
can increase osteocalcin expression. In this study,
increasing the dose was not accompanied by a linear
increase in osteocalcin expression, which was due to the
non-monotonic dose-response (NMDR). NMDR often
occurs in research on hormone replacement samples and
is due to differences in the level of affinities between
hormones and hormone replacement compounds to
target proteins such as receptors, cause responses to be
difficult to predict despite increased doses of treatments
[27, 28, 29]. The expression of osteocalcin in hFOB 1.19
cells after presenting the n-hexane fraction with various
doses showed that at concentrations of 62.5 ppm and 125
ppm was significantly different from negative control and
positive control (genistein), while at concentrations of
250 ppm it was not significantly different from negative
control and positive control (genistein). The result
expression of osteocalcin showed that 62.5 ppm was the
optimal concentration in increasing osteocalcin in hFOB
1.19 cells.
Of the 40 compounds detected, not all chromatogram
peaks can be identified in the metabolite profiling process
which is indicated by the presence of 26 known
compounds and 14 unknown compounds. The unknown
compounds are those that cannot be identified by the
database, which can be in the form of impurity or
degradation compounds that are still detected by the
instrument. In fact, they could be new and are not yet in
the database, especially unknown compounds that have
high concentrations [15, 30].
In silico study was performed by separating the 17β-
estradiol ligand with 1ERE protein, the criteria for ER-β
agonist compounds is the similarity of the compound to
the internal ligan. The molecular docking results of 1ERE
protein bonds with 17β-estradiol as internal ligands with
amino acids HIS (D: 524), ARG (D: 394), and GLU (D: 353).
If the compound can bind with at least two amino acids
HIS (D: 524), ARG (D: 394), and GLU (D: 353) then it is an
ER agonist, and the smaller the binding affinity value, the
more stable the compound [30, 31, 32]. 10 compounds
were predicted as ER-β agonists with proven similarities
to 17β-estradiol. This can be seen in (Table 4).
The research was conducted to study the bone formation
activity of the n-hexane fraction of Marsilea crenata Presl.
leaves in hFOB 1.19 cells with in vitro studies, metabolite
profiles, and in silico with 1ERE protein. The correlation
of the results of these studies showed that the increase in
bone formation activity in vitro was supported by the
prediction of 10 secondary metabolites in the n-hexane
fraction of Marsilea crenata Presl. which is proven to have
activity in silico.
CONCLUSION
The n-hexane fraction of Marsilea crenata Presl. has a
bone formation activity through the increased
Osteocalcin expression and the best dosage at 62.5 ppm
by 457.35 AU. There are 10 compounds predicted by
1ERE agonists which have been shown to have
similarities with 17β-estradiol. It gives an indication, that
phytoestrogen content of the n-hexane fraction of
Marsilea crenata Presl. leaves have a high potential as a
bone formation agent.
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Figure 1: Fluorescence intensity of osteocalcin, (A) negative control, (B) positive control (genistein), (C) 62.5 ppm, (D) 125
ppm, (E) 250 ppm
Figure 2: Osteocalcin expression in hFOB 1.19 cells. (*) significantly different from negative control and (**) significantly
different from a positive control
Figure 3: Chromatogram of n-hexane fraction ofMarsilea crenata Presl. leaves in methanol solvent
A B C D E
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Figure 4: Chromatogram of n-hexane fraction ofMarsilea crenata Presl. leaves in DCM solvent
Table 1: Fluorescence intensity of osteocalcin in hFOB 1.19 cells
Tratment Dose Fluorescence intensityOCN (AU)   SD
Negative control 8.94 ± 3.15
Positive control 17.40 ± 4.20
62.5 ppm 457.35 ± 43.11
125 ppm 98.62 ± 11.27
250 ppm 25.01 ± 6.39
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Table 2: Predicted compouds of n-hexane fraction ofMarsilea crenata Presl. leaves in DCM solvent




Formulas Compound Name Structure
Pub
med Activity





2 2.150 0.0103 191.1915 - - - - - -














6 5.628 1.0113 196.1100 196.1099 C11H16O3 Loliolide 27
Antioksidan (Yang,
2011)
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10 9.610 0.1038 552.2933 552.2935 C29H44O10 Antioside
17 -





12 10.010 0.4007 489.2860 489.2858 C12H31N19O3 Unknown Unknown - -
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13 10.389 1.3274 285.1365 285.1365 C17H19NO3 Hydromorphone 914 -








15 10.663 0.3964 508.2675 508.2673 C27H40O9 Ajugamarin E2 3 -
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16 10.780 0.5688 467.3263 467.3261 C27H41N5O2 asmarine E
10 -
17 10.905 2.6343 503.3061 503.3059 C3H29N29O2 - - - -























21 11.696 2.4617 573.3256 573.3255 C17H39N19O2S - - - -
22 11.801 0.8108 495.3602 495.3605 C18H45N11O5 - - - -
23 12.054 8.1891 495.3583 495.3579 C14H41N17O3 - - - -










25 12.338 4.1165 671.4105 671.4106 C32H57N5O10 - - - -
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26 12.538 13.0048 495.3336 495.3334 C5H37N25OS - - - -





























32 14.329 0.5906 523.3642 523.364 C14H41N19O3 - - - -
33 14.562 0.6677 341.3278 Unknown Unknown - - - -
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34 14.899 0.4148 304.2408 304.2403 C20H32O2 Mestanolone
181 -
Table 3: Predicted compouds of n-hexane fraction ofMarsilea crenata Presl. leaves in methanol solvent




Formulas Compound Name Structure
Pub
med Activity
1 1.076 11.7256 191.1621 - - - - - -
2 1.508 6.9230 123.0915 - - - - - -













5 12.001 9.3978 315.3144 - - - -
6 12.833 9.8565 436.2540 436.2542 C19H40N4O3S
2
- - - -
Table 4: 17β-estradiol and Compounds of n-hexane fraction ofMarsilea crenata Presl. leaves agonist with ER-β
No Compound Name BindingAffinity % Area
Amino














2 Cetylamine -5.9 47.6523 His 524;Glu 353
Hidrogen.
Alkyl
3 6-Chloro-9,10-dimethyl-12-oxatricyclo [5.3.2.01,6] -8.1 0.5735 His 524; Hidrogen.
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dodec-4-yl acetate Arg 349 Alkyl
4 (1Z)-3-[(Dimethylsulfamoyl)(2-methoxyethyl) amino]-N'-hydroxypropanimidamide -5.2 0.0355
His 524;
Glu 353 Hidrogen; Carbon
























6.3 9.2869 His 524;Glu 353
Hidrogen;
Unfavorable
10 Mestanolone -9.5 0.4148 His 524;Arg 394
Hidrogen;
Unfavorable
